Meet the Doctors
Dr. Paul DeRose
Paul DeRose, MD, is an independently practicing radiation oncologist on staff at Methodist
Richardson Medical Center. He attended medical school at the University
of Michigan and completed an internship at Oakwood Hospital in Wayne County,
Michigan. He completed his residency at UT Southwestern Medical School
where he was selected chief resident. He is board certified in radiation oncology.
His medical interests include lung cancer, breast cancer, head and neck cancer, prostate cancer and gastrointestinal cancers. He also has an interest in highly targeted techniques including stereotactic body radiation therapy, radiosurgery and brachtherapy.
Dr. DeRose was the recipient of the Lynn Sage Breast Cancer Achievement Award and the Grand Rounds Presenter Award.
Dr. DeRose research interest spans a number of areas. Some sample publications are:
Moran B. J., P. DeRose; G. Merrick; J. Hsu; M. Abdel-Wahab, V. Elayne Arterbery; J. P. Ciezki; S. J. Frank; N. M. Hahn; J. L. Mohler; S. A. Rosenthal; C. J. Rossi; Y. Yamada. Prostate. ACR Appropriateness Criteria® Definitive External Beam Irradiation in Stage T1 and T2 Prostate Cancer. Am J Clin Oncol. 2011 Dec;34(6):636-47.
P. DeRose, Thorpe P. E., Gerber, D “Development of bavituximab, a vascular targeting agent with immune-modulating properties, for lung cancer treatment.” Immunotherapy. 2011 Aug;3(8):933-44.
Boike T, Lotan Y, Cho L, Brindle J, DeRose P, Xie X, Yen J, Foster R, Pistenmaa D, Timmerman R. “A Phase I Dose Escalation Study of Stereotactic Body Radiation Therapy (SBRT) For Low And Intermediate Risk Prostate Cancer.” J Clin Oncol. 2011 May 20;29(15):2020-6.
Dr. Sam Bibawi
Dr. Sam Bibawi is an independently practicing medical oncologist and hematologist on
staff at Methodist Richardson Cancer Center, where he serves as medical
director. He completed his internal medicine residency at the University
of Virginia School of Medicine and his hematology-oncology fellowship
at the University of Vermont College of Medicine. With almost 20 years
of hematology and oncology experience, Dr. Bibawi relies on the most current
medical research, data, and protocols in treating his patients, and he
has authored several publications and book chapters. His primary areas
of expertise are breast cancer, lung cancer, complex hepatobiliary and
gastric cancer and colorectal cancer. He has particular interest in leukemia,
lymphoma, and complex benign hematology like aplastic anemia and other
disorders, honed by his experience as a faculty member at M.D. Anderson
Cancer Center. He is board certified in medical oncology, hematology,
and internal medicine.
Dr. Bibawi was voted by his peers as one the Best Doctors in Dallas/Collin County for 2010, 2011, 2013, 2014, 2015 and 2016 in D Magazine and a Texas Super Doctor by Texas Monthly in 2013, 2014 and 2015. In addition, Dr. Bibawi is designated on the prestigious Castle Connolly website as among the top 10 percent of US physicians in hematology. Dr. Bibawi enjoys spending time with his family, playing racquetball, cooking, and off-road driving.
Dr. Alan Trumbly
Dr. Alan Trumbly is an independently practicing medical oncologist on staff at Methodist
Richardson Cancer Center. He attended medical school at Oklahoma State
University. He completed his internal medicine residency and his medical
oncology fellowship at Scott & White in Temple, Texas. During his
fellowship, Dr. Trumbly proudly served as a physician at Central Texas
Veterans Health System and was nominated into the AOA Honor Medical Society.
He is board certified in internal medicine and medical oncology. His medical
interests include breast cancer, skin cancer, prostate cancer, complex
hepatobiliary and gastric cancer and malignant hematologic disorders such
as leukemia and lymphoma. His research background includes high risk familial
breast cancer testing and management. Dr. Trumbly enjoys spending time
with his family, playing with his dog, and staying active outdoors.